HLA-DR13: Difference between revisions
CSV import |
CSV import |
||
| Line 26: | Line 26: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
<gallery> | |||
File:DR Illustration.PNG|DR Illustration | |||
</gallery> | |||
Latest revision as of 05:59, 3 March 2025
HLA-DR13 is a human leukocyte antigen serotype within the HLA-DR serotype group. The serotype is determined by the antibody recognition of β-subunit of HLA-DR. This β-subunit is encoded by HLA-DRB1 gene and HLA-DR13 is encoded by the HLA-DRB1*13 allele group. This group currently contains many alleles. HLA-DR13 and HLA-DR14 split from a common ancestor, HLA-DR6.
Function[edit]
HLA-DR is a MHC class II cell surface receptor encoded by the human leukocyte antigen complex on chromosome 6 region 6p21.31. The complex is a group of genes that code for proteins found on the surface of cells that help the immune system to recognize foreign substances. HLA-DR is an antigen-presenting cell that is important in initiating immune responses.
Disease Association[edit]
HLA-DR13 is associated with a decreased risk of rheumatoid arthritis, systemic lupus erythematosus, and HIV infection. It is also associated with a decreased risk of progression to AIDS in HIV-infected individuals. However, it is associated with an increased risk of hepatitis B infection and leprosy.
Alleles[edit]
HLA-DRB1*13 group contains many alleles including DRB1*1301, DRB1*1302, DRB1*1303, DRB1*1304, and DRB1*1305. Each allele has a slightly different protein sequence, but all belong to the HLA-DR13 serotype group.
See Also[edit]
-
DR Illustration
